Evidence map›Paper›PMID 35038191›Full record

ArticleProteins2022

The amyloid concentric β-barrel hypothesis: Models of amyloid beta 42 oligomers and annular protofibrils.

Stewart R Durell, Rakez Kayed, H Robert Guy

Abstract read
In one paragraph

Article in Proteins, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Formation of amyloid loops in brain tissues is controlled by the flexibility of protofibril chains.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Stewart R DurellLaboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Rakez KayedUTMB Mitchell Center for Neurodegenerative Diseases, Department of Neurology, University of Texas Medical Branch, Galveston, Texas, USA.
H Robert GuyAmyloid Research Consultants (ARC), Cochiti Lake, New Mexico, USA.ORCID 0000-0002-8563-2335

Funding

Modeling Oligomeric Structures of Amyloid forming PeptidesZIABC012084 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI DURELL, STEWART · 2022 to 2022
$106k
Molecular Modeling of Ion Channel and Other Membrane ProteinsZ01BC011071 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI DURELL, STEWART · 2008 to 2008
$64k
Intramural NIH HHS Z01 BC011071
6 · The paper itself

Abstract

Amyloid beta (Aβ) peptides are a major contributor to Alzheimer's disease. They occur in differing lengths, each of which forms a multitude of assembly types. The most toxic soluble oligomers are formed by Aβ42; some of which have antiparallel β-sheets. Previously, our group proposed molecular models of Aβ42 hexamers in which the C-terminus third of the peptide (S3) forms an antiparallel 6-stranded β-barrel that is surrounded by an antiparallel barrel formed by the more polar N-terminus (S1) and middle (S2) portions. These hexamers were proposed to act as seeds from which dodecamers, octadecamers, both smooth annular protofibrils (sAPFs) and beaded annular protofibrils (bAPFs), and transmembrane channels form. Since then, numerous aspects of our models have been supported by experimental findings. Recently, NMR-based structures have been proposed for Aβ42 tetramers and octamers, and NMR studies have been reported for oligomers composed of ~32 monomers. Here we propose a range of concentric β-barrel models and compare their dimensions to image-averaged electron micrographs of both bAPFs and sAPFs of Aβ42. The smaller oligomers have 6, 8, 12, 16, and 18 monomers. These beads string together to form necklace-like bAPFs. These bAPRs gradually morph into sAPFs in which a S3 β-barrel is shielded on one or both sides by β-barrels formed from S1 and S2 segments.

Indexed as

Amyloid beta-PeptidesPeptide FragmentsAmyloidAmyloidogenic ProteinsHumansAmyloidAmyloid beta-Peptidesamyloid beta-protein (1-42)Amyloidogenic ProteinsPeptide Fragmentsamyloid beta 42amyloidsannular protofibrilsconcentric β-barrelsoligomersstructural models

Identifiers

PMID35038191
PMCPMC9390004

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.